Please assess the completion status of the following clinical trial:

Trial Title: Implications of Anesthetics on Sleep Consolidation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Primary Inclusion Criteria for Healthy volunteers~* Age between 18-35~* Native English speaking~* No hearing or speech difficulties~* No psychiatric, neurologic, or sleep disorders~* No chronic medical conditions, as reflected below under Primary Exclusion Criteria and above in 'Medical History'~* Non-smokers (within 3 months)~* Non-users of recreational or illicit drugs (including marijuana)~* Must be willing and able to pass the drug tests (no psychoactive substances), no ingestion of alcohol or sleep-altering drugs for the 48 hours prior to the study session.~* Normal weight~Primary Exclusion Criteria for Healthy volunteers~* Speech difficulties/disorders~* Hearing difficulties (including occluded or infected ear canals)~* Current hairstyles that do not allow the high-density EEG cap to make contact with the scalp (e.g., individuals with hair extensions, braids, dreadlocks or hairstyles that restrict the ability of electrodes to touch the scalp)~* Metal on/in/near their heads (including jewelry) that cannot be removed for the duration of the study~* Metal implants~* Serious abusers of alcohol or caffeine.~* Existing or suspected psychological or neurological disorders~* Pregnancy or suspected pregnancy (urine pregnancy test at visit 2)~* Chronic or transient (e.g., jet lag) problems with sleep; suspected sleep disorder~* Abnormal sleep habits, such as:~  * Sleeping less than 5 hours each night~ * Going to sleep before 8:00 PM or after 2:00 AM on a regular basis~ * Waking up before 5:00 AM or after 10:00 AM on a regular basis.~* Currently taking medications that regulate blood pressure; a history of high blood pressure, diabetes or stroke~* Chronic smokers~* Current use of aspirin, or other medications which increase bleeding, prior to the study session.~* Known drug allergies to anesthetics or a history of an adverse reaction to anesthesia.~* Known allergy to adhesives or electrode gel~* Medication that alters sleep, cognitive function, or both

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- Dexmedetomidine Arm (Type: EXPERIMENTAL): Dexmedetomidine: Administration of a 0.5 mcg/kg bolus followed by an infusion of 0.5-0.7 mcg/kg/hr, titrated up by 0.1 mcg every 1 minute until the subject spontaneously closes his or her eyes. When the subject spontaneously closes his or her eyes the infusion continues for 90 minutes from that point.

Based on this trial design, predict the completion outcome and termination type (if applicable).